A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer

Abstract

The lung metagene model provides a potential mechanism to refine the estimation of a patient's risk of disease recurrence and, in principle, to alter decisions regarding the use of adjuvant chemotherapy in early-stage NSCLC.